AAD 2026Abstract 75184
A novel dermocosmetic routine containing Vitamin B3 and 2-Mercaptonicotinyl Glycine significantly improves melasma after 3 months of daily use and provides a similar treatment outcome after 6 months compared to a 3-month treatment course following a switc
Passeron T, Kovylkina N, Rocio J, Cestari T, Faigenbaum-Feiges M, Fernandes E, Deloche-Bensmain C, Caberlotto E
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Pigmentary disorders
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.090 · Not in PubMed: details from Crossref